SCHEMBL1280041

SCHEMBL1280041

C=C(NC)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10269361 0.73
SCHEMBL10043069 0.73
SCHEMBL8348701 0.71
Methacrylic Acid SCHEMBL1025759 0.69
Methacrylic Acid SCHEMBL28516520 0.69 ALDH1A1 (0.45)
SCHEMBL346338 0.69
SCHEMBL8214989 0.69
SCHEMBL5068632 0.69
Formaldehyde SCHEMBL11802751 0.67
SCHEMBL20334478 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111718412-B Broad-spectrum microcystin monoclonal antibody and preparation method thereof 清华大学 2022-09-13 CN claimed
WO-2019160858-A1 POLYPRROLE-BASED EXTRACTION MATERIALS FOR MICROCYSTIN SEPARATION AND EXTRACTION THE UNIVERSITY OF TOLEDO (US) 2019-08-22 WO claimed
EP-2627664-B1 CYCLOSPORIN ANALOGS ALLERGAN INC (US) 2018-04-04 EP claimed
US-20150065433-A1 CYCLOSPORIN ANALOGS ALLERGAN, INC. (US) 2015-03-05 US claimed
EP-2627664-A1 CYCLOSPORIN ANALOGS Allergan, Inc. (US) 2013-08-21 EP claimed
WO-2012051194-A1 CYCLOSPORIN ANALOGS ALLERGAN, INC. (US) 2012-04-19 WO claimed
US-20120088734-A1 Cyclosporin Analogs ALLERGAN, INC. (US) 2012-04-12 US claimed
EP-2338057-A1 MASS MARKERS AND METHODS Brax Limited (GB) 2011-06-29 EP claimed
US-20110143951-A1 MASS MARKERS AND METHODS BRAX LIMITED (GB) 2011-06-16 US claimed
WO-2009153577-A1 MASS MARKERS AND METHODS BRAX LIMITED (GB) 2009-12-23 WO claimed
US-20070113353-A1 Polymeric Surface Treatment Compositions THE CLOROX COMPANY 2007-05-24 US claimed
EP-4746912-A1 ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES Simris Biologics GmbH (DE) 2026-05-27 EP disclosed
US-20250264433-A1 AN INTEGRATED MULTI-METHOD ELECTROCHEMICAL BIOSENSOR FOR RAPID-ON-SITE DETECTION AND/OR QUANTIFICATION OF SMALL MOLECULE TARGETS IN A SAMPLE THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI INSTITUTE) (IL) 2025-08-21 US disclosed
EP-4577248-A1 A METHOD OF MODIFYING AN ORGANIC CYTOTOXIN FOR USE AS A PAYLOAD IN AN ANTIBODY-DRUG CONJUGATE AND MODIFIED ORGANIC CYTOTOXINS DERIVED THEREFROM Simris Biologics GmbH (DE) 2025-07-02 EP disclosed
CN-119789876-A Method of modifying organic cytotoxins for use as payloads in antibody-drug conjugates and modified organic cytotoxins derived therefrom 辛利斯生物制药有限责任公司 2025-04-08 CN disclosed
EP-1265072-A1 Method for characterising polypeptides Xzillion GmbH &amp; CO.KG (DE) 2002-12-11 EP disclosed
EP-1210373-A2 CONGENER INDEPENDENT DETECTION OF MICROCYSTIN AND NODULARIN CONGENERS The Regent of the University of California (US) 2002-06-05 EP disclosed
WO-2001018059-A2 CONGENER INDEPENDENT DETECTION OF MICROCYSTIN AND NODULARIN CONGENERS THE REGENT OF THE UNIVERSITY OF CALIFORNIA (US) 2001-03-15 WO disclosed
US-4985522-A Polymers containing pendant urea groups THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1991-01-15 US disclosed
US-4906767-A Monomers with urea groups THE UNIVERSITY OF SOUTHERN MISSISSIPPI (US) 1990-03-06 US disclosed